Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in Parkinson's Disease
NCT07001150Phase 2Completed
- Sponsor
- Tanta University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silymarin in Parkinson's disease (PD), sponsored by Tanta University. Started May 2025; status: completed.
02
Drugs
silymarin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07001150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07001150.